Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-11
1998-12-01
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, C07K 1481, A61K 3855
Patent
active
058438955
ABSTRACT:
A potent serine protease inhibitor capable of inhibiting Factor Xa, Factor XIIa, plasma kallikrein, and human leukocyte elastase is provided. The inhibitor is provided in a pharmaceutical composition for treatment of diseases where inhibition of Factor Xa, Factor XIIa, plasma kallikrein, or HLE is indicated.
REFERENCES:
patent: 4711848 (1987-12-01), Insley et al.
patent: 5585259 (1996-12-01), Lauwereys et al.
Fletterick et al., "Deconvoluting Serpins" Structural Biology 1(4):201-203 (1994).
Huber et al., "Implications of the Three-Dimensional Structure of .alpha..sub.1 -Antitrypsinfor Structure and Function of Serpins" Biochemistry 28(23):8951-8966 (1989).
McGrath et al., "Ecotin: Lessons on Survival in a Protease-filled World" Protein Science 4:141-148 (1995).
McGrath et al., "Macromolecular Chelation as an Improved Mechanism of Protease Inhibition: Structure of Ecotin-Trypsin Complex" EMBO Journal 13(7):1502-1507 (1994).
Beckmann et al., "Semisynthesis of Arg 15, Glu 15, Met 15, and Nle 15-Aprotinin Involving Enzymatic Peptide Bond Resynthesis" J. Protein Chem. 8(1):101-113 (1989).
Bieth, Joseph G., "In Vivo Significance of Kinetic Constants of Protein Proteinase Inhibitors" Biochem. Med. 32:387-397 (1984).
Bigler et al., "Binding of amino acid side chains to preformed cavities: Interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues" Protein Science 2:786-799 (1993).
Bone, R.C., "Modulators of Coagulation; A Critical Appraisal of Their Role in Sepsis" Arch Intern Med 152:1381-1389 (1992).
Broze, Jr. et al., "Regulation of Coagulation by a Multivalent Kunitz-Type Inhibitor" Biochemistry 29(33):7538-7546 (1990).
Carrell et al., ".alpha. 1-Antitrypsin and the serpins: variation and countervariation" TIBS pp. 20-24 (1985).
Carvalho et al., "Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome" J. Lab Clin Med 112(2):270-277 (1988).
Chung et al., "Purification from Escherichia coli of a Periplasmic Protein That Is a Potent Inhibitor of Pancreatic Proteases" Journal of Biological Chemistry 258(18):11032-11038 (1983).
Colman, R.W., "The Role of Plasma Proteases In Septic Shock" The New England J. of Med. 320 (18):1207-1209 (1989).
Dunwiddie et al., "Site-Directed Analysis of the Functional Domains in the Factor Xa Inhibitor Tick Anticoagulant Peptide: Identification of Two Distinct Regions That Constitute the Enzyme Recognition Sites" Biochemistry 31:12126-12131 (1992).
Eisenberg et al., "Importance of Factor Xa in Determining the Procoagulant Activity of Whole-Blood Clots" J. Clin. Invest. 91:1877-1883 (1993).
Hae Shin et al., "Crystallization and Preliminary X-ray Crystallographic Analysis of the Protease Inhibitor Ecotin" J. Mol. Biol. 229:1157-1158 (1993).
Hauptmann et al., "Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro" Blood Coagulation and Fibrinolysis 4:577-582 (1993).
Heeb et al., "Inhibition of Activated Protein C by Recombinant .alpha. 1-Antitrypsin Variants with Substitution of Arginine or Leucine for Methionine 358" Journal of Biological Chemistry 265(4):2365-2369 (1990).
Lauwereys et al., "Ecotin as a Potent Factor Xa Inhibitor" Thrombosis and Haemostasis 69(6):783 Abstract 864 (1993).
Lee et al., "Molecular cloning of the Ecotin gene in Escherichia coli" FEBS 09974 287(1,2):53-56 (1991).
Mahoney et al., "Amino Acid Sequence and Secondary Structural Analysis of the Corn Inhibitor of Trypsin and Activated Hageman Factor" Journal of Biological Chemistry 259(13):8412-8416 (1984).
Martinez-Brotons et al., "Plasma Kallikrein-Kinin System in Patients with Uncomplicated Sepsis and Septic Shock-Comparison with Cardiogenic Shock" Thrombosis and Haemotasis 58(2):709-713 (1987).
McGrath et al., "Expression of the Protease Inhibitor Ecotin and Its Co-crystallization with Trypsin" J. Mol. Biol. 222:139-142 (1991).
McGrath et al., "The Sequence and Reactive Site of Ecotin" Journal of Biological Chemistry 266(10):6620-6625 (1991).
Mellott et al., "Enhancement of Recombinant Tissue Plasminogen Activator-Induced Reperfusion by Recombinant Tick Anticoagulant Peptide, A Selective Factor Xa Inhibitor, in a Canine Model of Femoral Arterial Thrombosis" Fibrinolysis 7:195-202 (1993).
Patston et al., "Reactivity of .alpha. 1-Antitrypsin Mutants against Proteolytic Enzymes of the Kallikrein-Kinin, Complement, and Fibrinolytic Systems" Journal of Biological Chemistry 265(18):10786-10791 (1990).
Pixley et al., "Activation of the Contact System in Lethal Hypotensive Bacteremia in a Baboon Model" Amer J. Pathology 140(4):897-906 (1992).
Pixley et al., "The Contact system Contributes to Hypotension but Not Disseminated Intravascular Coagulation in Lethal Bacteremia" J Clin Invest 91:61-68 (1993).
Schapira et al., "Protection by Recombinant .alpha. 1-Antitrypsin Ala 357 Arg 358 against Arterial Hypotension Induced by Factor XII Fragment" J. Clin. Invest. 80:582-585 (1987).
Schapira et al., "Serine Protease Inhibitors (Serpins)" Trends Cardiovasc Med 1(4):146-151 (1991).
Schmaier et al., "Contact Activation and Its Abnormalities" Hemostasis and Thrombosis; Basic Principles and Clinical Practice, Colman et al., 2nd edition pp. 18-38 (1987).
Schmeichel et al., "Septic Shock--What Do Physicians Want?" Biotechnology 10:264-267 (1992).
Scott et al., "Alpha-1-antitrypsin-Pittsburgh: A Potent Inhibitor of Human Plasma Factor X1a, Kallikrein, and Factor Xf" J. Clin. Invest. 77:631-634 (1986).
Taylor, Jr. et al., "DEGR-Factor Xa Blocks Disseminated Intravascular Coagulation Initiated by Escherichia coli Without Preventing Shock or Organ Damage" Blood 78(2):364-368 (1991).
Travis et al., "Kinetic Studies on the Interaction of .alpha. 1-Proteinase Inhibitor (Pittsburgh) with Trypsin-Like Serine Proteinases" Biol. Chem. Hoppe-Seyler 367:853-859 (1986).
Travis, James, Ph.D., "Structure, Function, and Control of Neutrophil proteinases" The Amer. Journ. of Med. 84(6A):37-42 (1988).
Vlasuk et al., "Comparison of the In Vivo Anticoagulant Properties of Standard Heparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venous Thrombosis" Thrombosis and Haemostasis 65(3):257-262 (1991).
Dennis Mark S.
Lazarus Robert A.
Ulmer Jana Seymour
Genentech Inc.
Kubinec Jeffrey S.
Lau Kawai
Wax Robert A.
LandOfFree
Pharmaceutical administration of ecotin homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical administration of ecotin homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical administration of ecotin homologs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395647